📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Oral 11ß-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial. (2022)

First Author: Ajjan RA

Attributed to: MICA: Treatment According to Response in Giant cEll arTeritis (TARGET) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1530/eje-21-1197

PubMed Identifier: 35113805

Publication URI: http://europepmc.org/abstract/MED/35113805

Type: Journal Article/Review

Volume: 186

Parent Publication: European journal of endocrinology

Issue: 4

ISSN: 0804-4643